| Authors: |
Porter R; Dana-Farber Cancer Institute, Boston, Massachusetts, USA rebecca_porter@dfci.harvard.edu., Bockorny B; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Corr BR; University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado, USA., Mahadevan D; The University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA., Wilky BA; University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado, USA., El-Khoueiry AB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Bullock AJ; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Hafez N; The Angeles Clinic and Research Institute, Los Angeles, California, USA., Moser J; HonorHealth Research Institute, Scottsdale, Arizona, USA., Martynova A; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Stebbing J; Anglia Ruskin University, School of Life Sciences, Cambridge, England, UK., Joshi B; Agenus Inc, Lexington, Massachusetts, USA., Bourdelais S; Agenus Inc, Lexington, Massachusetts, USA., Delepine C; Agenus Inc, Lexington, Massachusetts, USA., Chand D; Agenus Inc, Lexington, Massachusetts, USA., Wu W; Agenus Inc, Lexington, Massachusetts, USA., Johnson B; Agenus Inc, Lexington, Massachusetts, USA., Grossman JE; Agenus Inc, Lexington, Massachusetts, USA., O'Day SJ; Agenus Inc, Lexington, Massachusetts, USA., Matulonis UA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gordon MS; HonorHealth Research Institute, Scottsdale, Arizona, USA. |
